Want to see BCAB full AI Analyst Report?
BioAtla (BCAB) Q3 2024 Earnings Report
BCAB Q3 2024 EPS Results
- Actual EPS
- -$11.00
- Consensus EPS
- -$20.67
- Beat/Miss
- Beat by +$9.67
- One Year Ago EPS
- -$35.00
BCAB Q3 2024 Revenue Results
- Actual Revenue
- $11.00M
- Expected Revenue
- $0
- Beat/Miss
- Beat by +$11.00M
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q3 2024
- Date
- 11/07/2024
- Time
- After Close
- Conference Call
- Thursday, November 7, 2024
BCAB Upcoming Earnings
BioAtla's next earnings date is estimated for November 18, 2026, based on past reporting schedules.
Q3 2024 Earnings Call Audio
BCAB Q3 2024 Earnings Call
0:00 / 0:00
Q3 2024 Earnings Slide Deck
No slide deck is available for this earnings event.
Q3 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
BCAB Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 18, 2026 | 2026 (Q3) | ―- | -0.27 | ― | ― |
| Aug 06, 2026 | 2026 (Q2) | ―0.27 | -16 | 101.70% (+16.27) | |
| May 13, 2026 | 2026 (Q1) | ―- | -0.26 | ― | |
| Mar 31, 2026 | 2025 (Q4) | -12.00-8.00 | -13 | 38.46% (+5.00) | |
| Nov 13, 2025 | 2025 (Q3) | -14.83-13.50 | -11 | -22.73% (-2.50) | |
| Aug 07, 2025 | 2025 (Q2) | -14.00-16.00 | -22 | 27.27% (+6.00) | |
| May 06, 2025 | 2025 (Q1) | -14.67-13.00 | -24 | 45.83% (+11.00) | |
| Mar 27, 2025 | 2024 (Q4) | -19.25-15.00 | -28 | 46.43% (+13.00) | |
| Nov 07, 2024 | 2024 (Q3) | -20.67-11.00 | -35 | 68.57% (+24.00) | |
| Aug 08, 2024 | 2024 (Q2) | -22.40-22.00 | -37.5 | 41.33% (+15.50) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
